Marco Montanaro

1.3k total citations
32 papers, 855 citations indexed

About

Marco Montanaro is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Marco Montanaro has authored 32 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Marco Montanaro's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Marco Montanaro is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Marco Montanaro collaborates with scholars based in Italy, Malaysia and France. Marco Montanaro's co-authors include Pellegrino Musto, Sylvain Doré, Vincenzo Callea, Tommaso Caravita, Patrizia Falco, Giovannino Ciccone, Sara Bringhen, Francesca Gay, Roberto Ria and Antonietta Falcone and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Marco Montanaro

29 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Montanaro Italy	15	424	334	331	227	148	32	855
Sumiko Kobayashi Japan	14	281 0.7×	161 0.5×	147 0.4×	97 0.4×	157 1.1×	51	747
J Cahn France	22	1.2k 2.7×	392 1.2×	282 0.9×	216 1.0×	125 0.8×	70	1.6k
Wanzhuo Xie China	16	476 1.1×	219 0.7×	467 1.4×	106 0.5×	97 0.7×	81	1.1k
Fabio Forghieri Italy	19	329 0.8×	165 0.5×	175 0.5×	128 0.6×	187 1.3×	41	743
Filippo Marmont Italy	20	1.1k 2.6×	508 1.5×	591 1.8×	287 1.3×	92 0.6×	46	1.5k
J Hermann Germany	14	382 0.9×	349 1.0×	249 0.8×	50 0.2×	77 0.5×	30	926
Ahmet Emre Eşkazan Türkiye	15	443 1.0×	125 0.4×	109 0.3×	289 1.3×	84 0.6×	130	813
Enrico Morello Italy	13	174 0.4×	114 0.3×	91 0.3×	65 0.3×	176 1.2×	59	518
T. de Witte Netherlands	23	875 2.1×	394 1.2×	254 0.8×	266 1.2×	148 1.0×	54	1.4k
Antonio Spadea Italy	18	539 1.3×	469 1.4×	281 0.8×	319 1.4×	220 1.5×	59	1.2k

Countries citing papers authored by Marco Montanaro

Since Specialization

Citations

This map shows the geographic impact of Marco Montanaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Montanaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Montanaro more than expected).

Fields of papers citing papers by Marco Montanaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Montanaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Montanaro. The network helps show where Marco Montanaro may publish in the future.

Co-authorship network of co-authors of Marco Montanaro

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Montanaro. A scholar is included among the top collaborators of Marco Montanaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Montanaro. Marco Montanaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fiorini, Alessia, Marco Dell’Aquila, Daniele Remotti, et al.. (2025). Spleen Involvement at Diagnosis of Multiple Myeloma: A Case Report and Literature Review. Cancer Reports. 8(3). e70160–e70160.

Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations

Autore, Francesco, Idanna Innocenti, Francesco Corrente, et al.. (2020). Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region. Frontiers in Oncology. 10. 848–848. 2 indexed citations

Andriani, Alessandro, Elena Maria Elli, Giulio Trapè, et al.. (2019). Treatment of Philadelphia‐negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors. Hematological Oncology. 37(3). 291–295. 10 indexed citations

Zanelli, Magda, Maurizio Zizzo, Marco Montanaro, et al.. (2019). Fibrin-associated large B-cell lymphoma: first case report within a cerebral artery aneurysm and literature review. BMC Cancer. 19(1). 916–916. 19 indexed citations

Veroli, Ambra Di, Alessia Campagna, Marianna De Muro, et al.. (2018). Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?. Leukemia Research. 76. 65–69. 6 indexed citations

Breccia, Massimo, Alessandro Andriani, Marco Montanaro, et al.. (2016). Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN. Annals of Hematology. 96(3). 387–391. 13 indexed citations

Latagliata, Roberto, Ambra Di Veroli, Pasquale Niscola, et al.. (2015). Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. European Journal Of Haematology. 96(6). 643–649. 16 indexed citations

Andriani, Alessandro, Marco Montanaro, Maria Teresa Voso, et al.. (2015). Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN. Leukemia Research. 39(8). 801–804. 20 indexed citations

10.

Andriani, Alessandro, Marco Montanaro, Maria Teresa Voso, et al.. (2014). The Experience of Gruppo Laziale for the Study of Ph-, Chronic Myeloproliferative Syndromes in the Treatment of Myeloproliferative Neoplasms in Blastic Phase with Azacytidine. Blood. 124(21). 3164–3164. 1 indexed citations

11.

Latagliata, Roberto, Pasquale Niscola, Fabrizio Ciccone, et al.. (2013). Deferasirox In The Treatment Of Iron Overload During Myeloproliferative Neoplasms (MPN). Blood. 122(21). 1594–1594. 1 indexed citations

12.

Pisani, Francesco, Maria Teresa Petrucci, Diana Giannarelli, et al.. (2012). IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy. Journal of Experimental & Clinical Cancer Research. 31(1). 17–17. 19 indexed citations

13.

Lanini, Simone, Silvia D’Arezzo, Vincenzo Puro, et al.. (2011). Molecular Epidemiology of a Pseudomonas aeruginosa Hospital Outbreak Driven by a Contaminated Disinfectant-Soap Dispenser. PLoS ONE. 6(2). e17064–e17064. 79 indexed citations

14.

Laurenti, Luca, Michela Tarnani, Ilaria Nichele, et al.. (2011). The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience. American Journal of Hematology. 86(12). 1007–1012. 37 indexed citations

15.

Palumbo, Antonio, Sara Bringhen, Anna Marina Liberati, et al.. (2008). Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial. Blood. 112(8). 3107–3114. 250 indexed citations

16.

Boccadoro, Mario, Sara Galimberti, Maria Teresa Petrucci, et al.. (2008). Melphalan 200 Mg/m2 (Mel200) Versus Melphalan 100 Mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study. Blood. 112(11). 3316–3316.

17.

Bianco, Elvira, Elisa Marcucci, Andrea Mele, et al.. (2006). 451 High prevalence of hepatitis B virus infection in b-cell non-hodgkin lymphoma. Journal of Hepatology. 44. S168–S168. 7 indexed citations

18.

Palumbo, Antonio, Sara Galimberti, Pellegrino Musto, et al.. (2005). Oral Melphalan, Prednisone and Thalidomide for Multiple Myeloma.. Blood. 106(11). 779–779. 7 indexed citations

19.

Molica, Stefano, Francesca Romana Mauro, Vincenzo Callea, et al.. (2005). A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Leukemia & lymphoma. 46(4). 553–560. 22 indexed citations

20.

Bianco, Elvira, Fabrizio Marcucci, Alfonso Mele, et al.. (2004). Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.. PubMed. 89(1). 70–6. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact